GM-CSF can stimulate and activate antigen-presenting cells (APCs), which can process and present tumor antigens to CD4+ helper T cells and CD8+ cytotoxic T lymphocytes (CTL) (61, 62). The gene discussed is CSF2; the disease is neoplasm.